Clinical trials
Completed Phase 2/3 trials in the Netherlands
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
135 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 3 |
| 2001 | 6 |
| 2002 | 4 |
| 2003 | 2 |
| 2004 | 8 |
| 2005 | 9 |
| 2006 | 6 |
| 2007 | 6 |
| 2008 | 8 |
| 2009 | 7 |
| 2010 | 5 |
| 2011 | 4 |
| 2012 | 12 |
| 2013 | 4 |
| 2014 | 9 |
| 2015 | 7 |
| 2016 | 3 |
| 2017 | 5 |
| 2018 | 8 |
| 2019 | 4 |
| 2020 | 6 |
| 2021 | 1 |
| 2022 | 4 |
| 2023 | 3 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 135 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Radboud University Medical Center | 12 |
| Boehringer Ingelheim | 4 |
| Sanofi | 4 |
| Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 3 |
| AstraZeneca | 3 |
| Bayer | 3 |
| Erasmus Medical Center | 3 |
| Foundation for Liver Research | 3 |
| Novartis Pharmaceuticals | 3 |
| University Medical Center Groningen | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Coronary Artery Disease | 5 |
| Hemophilia A | 4 |
| Neoplasm Metastasis | 4 |
| Alzheimer Disease | 3 |
| Colitis, Ulcerative | 3 |
| Diabetes Mellitus, Type 1 | 3 |
| Genetic Diseases, Inborn | 3 |
| HIV Infections | 3 |
| Heart Failure | 3 |
| Neuralgia | 3 |
Trials
Showing 1 to 25 of 135. Each trial links to its page on Pharma Observatory.
35 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.